Projects funded by the NCN
Evaluation of the molecular basis of beta-hydroxy-beta-methylbutyrate as a tool to support the medical treatment of muscular dystrophies - studies in vivo and in vitro
2020/37/B/NZ5/01744
Keywords:
dystrophy human DMD cells GRMD dogs rats HMB steroids cell cultures study in vivo and in vitro
Descriptors:
- NZ5_007:
- NZ5_008:
- NZ5_009:
Panel:
NZ5 - Human and animal noninfectious diseases: etiology, mechanisms, diagnosis and treatment of diseases, poisonings and injuries (without neurological diseases)
Host institution :
Szkoła Główna Gospodarstwa Wiejskiego w Warszawie, Instytut Medycyny Weterynaryjnej
woj. mazowieckie
Principal investigator (from the host institution):
Number of co-investigators in the project: 6
Call: OPUS 19 - announced on 2020-03-16
Amount awarded: 1 232 400 PLN
Project start date (Y-m-d): 2021-01-26
Project end date (Y-m-d): 2026-01-25
Project duration:: 60 months (the same as in the proposal)
Project status: Pending project
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.
Information in the final report
- Publication in academic press/journals (1)
- Does Beta-Hydroxy-Beta-Methylbutyrate Have Any Potential to Support the Treatment of Duchenne Muscular Dystrophy in Humans and Animals?Authors:Abdolvahab Ebrahimpour Gorji, Piotr Ostaszewski, Kaja Urbańska, Tomasz SadkowskiAcademic press:Biomedicines (rok: 2023, tom: 11, strony: 2329), Wydawca: MDPIStatus:PublishedDOI:10.3390/biomedicines11082329 - link to the publication